Literature DB >> 21487028

The athlete's heart vs. the failing heart: can signaling explain the two distinct outcomes?

Kate L Weeks1, Julie R McMullen.   

Abstract

Cardiac remodeling is typically associated with disease and can lead to heart failure. In contrast, remodeling that occurs in the athlete's heart is considered an adaptive physiological response. This review provides an overview of signaling mechanisms responsible for inducing left ventricular hypertrophy in the athlete's heart and in settings of pathological hypertrophy and heart failure.

Entities:  

Mesh：

Year:  2011        PMID： 21487028     DOI： 10.1152/physiol.00043.2010

Source DB:  PubMed          Journal:  Physiology (Bethesda)        ISSN： 1548-9221


  51 in total

1.  Relationship between muscle sympathetic nerve activity and aortic wave reflection characteristics in aerobic- and resistance-trained subjects.

Authors:  Michael M Smith; C A Tony Buffington; Robert L Hamlin; Steven T Devor
Journal:  Eur J Appl Physiol       Date:  2015-08-06       Impact factor: 3.078

Review 2.  Influence of Physical Activity on Hypertension and Cardiac Structure and Function.

Authors:  Sheila M Hegde; Scott D Solomon
Journal:  Curr Hypertens Rep       Date:  2015-10       Impact factor: 5.369

3.  Reduced endoglin activity limits cardiac fibrosis and improves survival in heart failure.

Authors:  Navin K Kapur; Szuhuei Wilson; Adil A Yunis; Xiaoying Qiao; Emily Mackey; Vikram Paruchuri; Corey Baker; Mark J Aronovitz; S Ananth Karumanchi; Michelle Letarte; David A Kass; Michael E Mendelsohn; Richard H Karas
Journal:  Circulation       Date:  2012-05-16       Impact factor: 29.690

Review 4.  Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload.

Authors:  Gabriele G Schiattarella; Joseph A Hill
Journal:  Circulation       Date:  2015-04-21       Impact factor: 29.690

Review 5.  Aerobic exercise training promotes physiological cardiac remodeling involving a set of microRNAs.

Authors:  Tiago Fernandes; Valério G Baraúna; Carlos E Negrão; M Ian Phillips; Edilamar M Oliveira
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-06-12       Impact factor: 4.733

6.  Peroxisome proliferator-activated receptor-γ coactivator 1 α1 induces a cardiac excitation-contraction coupling phenotype without metabolic remodelling.

Authors:  Maija Mutikainen; Tomi Tuomainen; Nikolay Naumenko; Jenni Huusko; Boris Smirin; Svetlana Laidinen; Krista Kokki; Heidi Hynynen; Seppo Ylä-Herttuala; Merja Heinäniemi; Jorge L Ruas; Pasi Tavi
Journal:  J Physiol       Date:  2016-12-01       Impact factor: 5.182

7.  The relationship between galectin-3 levels and fragmented QRS (fQRS) in patients with heart failure with reduced left ventricular ejection fraction.

Authors:  Hasan Ali Barman; Eser Durmaz; Adem Atici; Serdar Kahyaoglu; Ramazan Asoglu; Irfan Sahin; Baris Ikitimur
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-06-02       Impact factor: 1.468

Review 8.  Mitochondria and cardiovascular diseases-from pathophysiology to treatment.

Authors:  Gerasimos Siasos; Vasiliki Tsigkou; Marinos Kosmopoulos; Dimosthenis Theodosiadis; Spyridon Simantiris; Nikoletta Maria Tagkou; Athina Tsimpiktsioglou; Panagiota K Stampouloglou; Evangelos Oikonomou; Konstantinos Mourouzis; Anastasios Philippou; Manolis Vavuranakis; Christodoulos Stefanadis; Dimitris Tousoulis; Athanasios G Papavassiliou
Journal:  Ann Transl Med       Date:  2018-06

Review 9.  Remodeling and dedifferentiation of adult cardiomyocytes during disease and regeneration.

Authors:  Marten Szibor; Jochen Pöling; Henning Warnecke; Thomas Kubin; Thomas Braun
Journal:  Cell Mol Life Sci       Date:  2013-12-10       Impact factor: 9.261

10.  Inducible re-expression of HEXIM1 causes physiological cardiac hypertrophy in the adult mouse.

Authors:  Monica M Montano; Candida L Desjardins; Yong Qui Doughman; Yee-Hsee Hsieh; Yanduan Hu; Heather M Bensinger; Connie Wang; Julian E Stelzer; Thomas E Dick; Brian D Hoit; Margaret P Chandler; Xin Yu; Michiko Watanabe
Journal:  Cardiovasc Res       Date:  2013-04-11       Impact factor: 10.787
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.